3 terminated, 2 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
| Not applicable | 1 | Terminated 1 |
Follow Brain Neoplasms, Malignant: new trials by email Literature Review of Brain Neoplasms, Malignant trials Research Report on Brain Neoplasms, Malignant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer Radiation Therapy, AZD1390 - Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme | Phase 1 | Completed | AstraZeneca | 159 | 2018-04-02 | 2026-10-15 |
| CEST- Glucose Enhanced MRI for Metastatic Brain Tumours Magnetic resonance imaging, Gadovist (Gadobutrol), 50% dextrose solution - Brain Neoplasms, Malignant, Metastasis | Phase 2 | Terminated | British Columbia Cancer Agency | 3 | 2016-10-01 | 2019-01-28 |
| More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery 5-ALA (Gliolan) - Benign Neoplasms, Brain, Brain Cancer | Phase 2 | Withdrawn | Constantinos Hadjipanayis | 2015-11-01 | 2016-05-17 | |
| Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors pioglitazone, Pioglitazone - Brain Neoplasms, Malignant, Brain Neoplasms, Benign | Phase 1 | Completed | Wake Forest University Health Sciences | 18 | 2010-08-01 | 2018-08-01 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors Methylphenidate, Placebo - ALL, Childhood, Leukemia, Lymphoblastic | Not applicable | Terminated | University of Minnesota | 1 | 2010-05-01 | 2015-03-27 |
| Risk Factors for Adult-Onset Brain Tumors Brain Neoplasm, Primary, Brain Neoplasms, Malignant | Terminated | Vanderbilt University Medical Center | 850 | 2003-10-01 | 2021-02-21 |
Brain Neoplasms (6) · Glioblastoma (3) · Astrocytoma (1) · Cognitive Dysfunction (1) · Glioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Inhibition, Psychological (1) · Memory Disorders (1) · Meningeal Neoplasms (1) · Meningioma (1) · Neoplasm Metastasis (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Brain Diseases (6) · Central Nervous System Diseases (6) · Central Nervous System Neoplasms (6) · Neoplasms (6) · Neoplasms by Site (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Neoplasms by Histologic Type (4) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Astrocytoma (2) · Glioma (2)
AZD1390 (1) · Aminolevulinic Acid (1) · Magnetic Resonance Spectroscopy (1) · Methylphenidate (1) · Pioglitazone (1) · Radiotherapy (1) · gadobutrol (1)
AstraZeneca (1) · British Columbia Cancer Agency (1) · Constantinos Hadjipanayis (1) · University of Minnesota (1) · Vanderbilt University Medical Center (1) · Wake Forest University Health Sciences (1)
United States (5) · Canada (1) · Japan (1) · United Kingdom (1)
Alicia Kunin-Batson, Ph.D. (1) · Anthony Chalmers (1) · Brandon Imber (1) · Burt Nabors, MD (1) · Costas Hadjipanayis, MD, PhD (1) · Deborah Forst (1) · Jan Drappatz (1) · Jeffrey Olson, MD (1) · Kathleen M. Egan, DSc (1) · Kazuhiko Mishima (1) · Louise Murray (1) · Mariza Daras (1) · Michael Chan (1) · Michael McKenzie (1) · Patrick Wen (1)
2017 (1), R01CA176659 (1), R21CA186169 (1)